Potential new therapeutic targets for pathological pruritus

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 8, 2013, Pages 1228-1234

  Kuraishi, Yasushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Dorsal horn neuron; Itch inhibitory system; Itch mediator; Keratinocyte; Primary sensory neuron; Pruritic disease

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ARACHIDONATE 5 LIPOXYGENASE; AUTOTAXIN; BOMBESIN ANTAGONIST; BOMBESIN BB2 RECEPTOR; BOMBESIN RECEPTOR; GASTRIN RELEASING PEPTIDE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; HYDROLASE; INTERLEUKIN 31; INTERLEUKIN 31 RECEPTOR A; KAPPA OPIATE RECEPTOR; LEUKOTRIENE A4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; MU OPIATE RECEPTOR; NEUROMEDIN B; PROTEINASE ACTIVATED RECEPTOR 2; RECOMBINANT CYTOKINE; SPHINGOMYELIN; SPHINGOMYELIN GLUCOSYLCERAMIDE DEACYLASE; TOLL LIKE RECEPTOR 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 3;

ARTICLE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PRURITUS; TREATMENT OUTCOME;

EID: 84883172499     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00343     Document Type: Article

References (103)

1. Abelson MB, McLaughlin JT, Gomes PJ. Antihistamines in ocular allergy: are they all created equal? Curr. Allergy Asthma Rep., 11, 205-211 (2011).
2. 2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice. Eur. J. Pharmacol., 367, 361-371 (1999).
3. 4 in itching in a mouse model of ocular allergy. Exp. Eye Res., 98, 97-103 (2012).
4. Inami Y, Andoh T, Sasaki A, Kuraishi Y. Topical surfactant-induced pruritus: involvement of histamine released from epidermal keratinocytes. J. Pharmacol. Exp. Ther., 344, 459-466 (2013).
5. Inami Y, Andoh T, Kuraishi Y. Prevention of topical surfactantinduced itch-related responses by chlorogenic acid through the inhibition of increased histamine production in the epidermis. J. Pharmacol. Sci., 121, 242-245 (2013).
6. 4 receptors in allergic inflammation: the search for new antihistamines. Nat. Rev. Drug Discov., 7, 41-53 (2008).
7. 3 receptors. Clin. Exp. Allergy, 34, 456-459 (2004).
8. 4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp. Dermatol., 18, 57-63 (2009).
9. 4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J. Allergy Clin. Immunol., 119, 176-183 (2007).
10. Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy, 67, 1014-1022 (2012).
11. 4 receptor antagonist. J. Toxicol. Sci., 34, 427-431 (2009).
12. Arthur RP, Shelley WB. The role of proteolytic enzymes in the production of pruritus in man. J. Invest. Dermatol., 25, 341-346 (1955).
13. Ui H, Andoh T, Lee JB, Nojima H, Kuraishi Y. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur. J. Pharmacol., 530, 172-178 (2006).
14. Andoh T, Takayama Y, Yamakoshi T, Lee JB, Sano A, Shimizu T, Kuraishi Y. Involvement of serine protease and proteinaseactivated receptor 2 in dermatophyte-associated itch in mice. J. Pharmacol. Exp. Ther., 343, 91-96 (2012).
15. Hägermark Ö, Rajka G, Bergqvist U. Experimental itch in human skin elicited by rat mast cell chymase. Acta Derm. Venereol., 52, 125-128 (1972).
16. Tsujii K, Andoh T, Lee JB, Kuraishi Y. Activation of proteinaseactivated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice. J. Pharmacol. Sci., 108, 385-388 (2008).
17. Takahagi S, Shindo H, Watanabe M, Kameyoshi Y, Hide M. Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate. Acta Derm. Venereol., 90, 425-426 (2010).
18. Andoh T, Yoshida T, Lee JB, Kuraishi Y. Cathepsin E induces itch-related response through the production of endothelin-1 in mice. Eur. J. Pharmacol., 686, 16-21 (2012c).
19. 2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice. Br. J. Pharmacol., 159, 888-897 (2010).
20. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci., 23, 6176-6180 (2003).
21. Tsujii K, Andoh T, Ui H, Lee JB, Kuraishi Y. Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itchassociated response in mice with atopy-like dermatitis. J. Pharmacol. Sci., 109, 388-395 (2009).
22. Zhu Y, Peng C, Xu JG, Liu YX, Zhu QG, Liu JY, Li FQ, Wu JH, Hu JH. Participation of proteinase-activated receptor-2 in passive cutaneous anaphylaxis-induced scratching behavior and the inhibitory effect of tacrolimus. Biol. Pharm. Bull., 32, 1173-1176 (2009).
23. Reddy VB, Iuga AO, Shimada SG, LaMotte RH, Lerner EA. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J. Neurosci., 28, 4331-4335 (2008).
24. Moormann C, Artuc M, Pohl E, Varga G, Buddenkotte J, Vergnolle N, Brehler R, Henz BM, Schneider SW, Luger TA, Steinhoff M. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J. Invest. Dermatol., 126, 746-755 (2006).
25. Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ Jr. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J. Neurosci., 27, 10007-10014 (2007).
26. Nakano T, Andoh T, Lee JB, Kuraishi Y. Different dorsal horn neurons responding to histamine and allergic itch stimuli. Neuroreport, 19, 723-726 (2008).
27. Namer B, Carr R, Johanek LM, Schmelz M, Handwerker HO, Ringkamp M. Separate peripheral pathways for pruritus in man. J. Neurophysiol., 100, 2062-2069 (2008).
28. Akiyama T, Carstens MI, Carstens E. Enhanced responses of lumbar superficial dorsal horn neurons to intradermal PAR-2 agonist but not histamine in a mouse hindpaw dry skin itch model. J. Neurophysiol., 105, 2811-2817 (2011).
29. Okamoto R, Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Imokawa G. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J. Lipid Res., 44, 93-102 (2003).
30. Imokawa G. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J. Dermatol. Sci., 55, 1-9 (2009).
31. Choi H, Kim S, Kim HJ, Kim KM, Lee CH, Shin JH, Noh M. Sphingosylphosphorylcholine down-regulates filaggrin gene transcription through NOX5-based NADPH oxidase and cyclooxygenase-2 in human keratinocytes. Biochem. Pharmacol., 80, 95-103 (2010).
32. 4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp. Dermatol., 20, 894-898 (2011).
33. Kim HJ, Kim H, Han ES, Park SM, Koh JY, Kim KM, Noh MS, Kim JJ, Lee CH. Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632. Eur. J. Pharmacol., 583, 92-96 (2008).
34. 4 mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. J. Invest. Dermatol., 129, 2854-2860 (2009).
35. Ceballos A, Sabatté J, Nahmod K, Martínez D, Salamone G, Vermeulen M, Maggini J, Salomón H, Geffner J. Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12. Immunology, 121, 328-336 (2007).
36. Kim HJ, Kim KM, Koh JY, Noh MS, Park MK, Lee HJ, Kim SY, Lee CH. Sphingosylphosphorylcholine induces degranulation of mast cells in the skin and plasma exudation in the ears of mice. J. Dermatol. Sci., 57, 57-59 (2010).
37. 2, induces itch-associated responses in mice. Eur. J. Pharmacol., 353, 93-96 (1998).
38. Tsukumo Y, Harada D, Manabe H. Pharmacological characterization of itch-associated response induced by repeated application of oxazolone in mice. J. Pharmacol. Sci., 113, 255-262 (2010).
39. Kuraishi Y, Ohtsuka E, Nakano T, Kawai S, Andoh T, Nojima H, Kamimura K. Possible involvement of 5-lipoxygenase metabolite in itch-associated response of mosquito allergy in mice. J. Pharmacol. Sci., 105, 41-47 (2007).
40. 4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med., 192, 421-432 (2000).
41. 4 receptor on the dorsal root ganglion neurons in mice. Brain Res. Mol. Brain Res., 137, 263-266 (2005).
42. 4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice. Biol. Pharm. Bull., 33, 1050-1053 (2010).
43. 4-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1. FASEB J., 27, 1664-1673 (2013).
44. Willemsen MA, Lutt MA, Steijlen PM, Cruysberg JR, van der Graaf M, Nijhuis-van der Sanden MW, Pasman JW, Mayatepek E, Rotteveel JJ. Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome. Eur. J. Pediatr., 160, 711-717 (2001).
45. Woodmansee DP, Simon RA. A pilot study examining the role of zileuton in atopic dermatitis. Ann. Allergy Asthma Immunol., 83, 548-552 (1999).
46. Kim DK, Kim HJ, Sung KS, Kim H, Cho SA, Kim KM, Lee CH, Kim JJ. 12(S)-HPETE induces itch-associated scratchings in mice. Eur. J. Pharmacol., 554, 30-33 (2007).
47. Kim HJ, Kim DK, Kim H, Koh JY, Kim KM, Noh MS, Lee S, Kim S, Park SH, Kim JJ, Kim SY, Lee CH. Involvement of the BLT2 receptor in the itch-associated scratching induced by 12(S)-lipoxygenase products in ICR mice. Br. J. Pharmacol., 154, 1073-1078 (2008).
48. Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta, 1781, 513-518 (2008).
49. Kremer AE, Martens JJ, Kulik W, Ruëff F, Kuiper EM, van Buuren HR, van Erpecum KJ, Kondrackiene J, Prieto J, Rust C, Geenes VL, Williamson C, Moolenaar WH, Beuers U, Oude Elferink RP. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology, 139, 1008-1018, e1 (2010).
50. Hashimoto T, Ohata H, Momose K. Itch-scratch responses induced by lysophosphatidic acid in mice. Pharmacology, 72, 51-56 (2004).
51. Kremer AE, van Dijk R, Leckie P, Schaap FG, Kuiper EM, Mettang T, Reiners KS, Raap U, van Buuren HR, van Erpecum KJ, Davies NA, Rust C, Engert A, Jalan R, Oude Elferink RP, Beuers U. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology, 56, 1391-1400 (2012).
52. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol., 5, 752-760 (2004).
53. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol., 117, 411-417 (2006).
54. Nobbe S, Dziunycz P, Mühleisen B, Bilsborough J, Dillon SR, French LE, Hofbauer GF. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm. Venereol., 92, 24-28 (2012).
55. Takaoka A, Arai I, Sugimoto M, Honma Y, Futaki N, Nakamura A, Nakaike S. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp. Dermatol., 15, 161-167 (2006).
56. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Grønhøj-Larsen C, Matsushima K. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp. Dermatol., 18, 35-43 (2009).
57. Tamura S, Morikawa Y, Miyajima A, Senba E. Expression of oncostatin M receptor β in a specific subset of nociceptive sensory neurons. Eur. J. Neurosci., 17, 2287-2298 (2003).
58. Bando T, Morikawa Y, Komori T, Senba E. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns. Neuroscience, 142, 1263-1271 (2006).
59. Kasraie S, Niebuhr M, Baumert K, Werfel T. Functional effects of interleukin 31 in human primary keratinocytes. Allergy, 66, 845-852 (2011).
60. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, Basbaum AI, Han SK. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc. Natl. Acad. Sci. U.S.A., 106, 11330-11335 (2009).
61. 2 and 12-lipoxygenase. J. Neurosci., 27, 2331-2337 (2007).
62. Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, Tominaga M, Noguchi K. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J. Neurosci., 24, 4293-4299 (2004).
63. Peier AM, Reeve AJ, Andersson DA, Moqrich A, Earley TJ, Hergarden AC, Story GM, Colley S, Hogenesch JB, McIntyre P, Bevan S, Patapoutian A. A heat-sensitive TRP channel expressed in keratinocytes. Science, 296, 2046-2049 (2002).
64. Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong JA, Lawson D, Ge P, Lilly J, Silos-Santiago I, Xie Y, DiStefano PS, Curtis R, Clapham DE. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature, 418, 181-186 (2002).
65. Yoshioka T, Imura K, Asakawa M, Suzuki M, Oshima I, Hirasawa T, Sakata T, Horikawa T, Arimura A. Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. J. Invest. Dermatol., 129, 714-722 (2009).
66. Yamamoto-Kasai E, Imura K, Yasui K, Shichijou M, Oshima I, Hirasawa T, Sakata T, Yoshioka T. TRPV3 as a therapeutic target for itch. J. Invest. Dermatol., 132, 2109-2112 (2012).
67. Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, Tokunaga A, Noguchi K. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/cfibers and colocalization with trk receptors. J. Comp. Neurol., 493, 596-606 (2005).
68. Wang H, Woolf CJ. Pain TRPs. Neuron, 46, 9-12 (2005).
69. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, Dong X, Bautista DM. TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat. Neurosci., 14, 595-602 (2011).
70. Dai Y, Wang S, Tominaga M, Yamamoto S, Fukuoka T, Higashi T, Kobayashi K, Obata K, Yamanaka H, Noguchi K. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J. Clin. Invest., 117, 1979-1987 (2007).
71. Liu T, Ji RR. Oxidative stress induces itch via activation of transient receptor potential subtype ankyrin 1 in mice. Neurosci. Bull., 28, 145-154 (2012).
72. Fleming MS, Ramos D, Han SB, Zhao J, Son YJ, Luo W. The majority of dorsal spinal cord gastrin releasing peptide is synthesized locally whereas neuromedin B is highly expressed in pain- and itch-sensing somatosensory neurons. Mol. Pain, 8, 52 (2012).
73. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature, 448, 700-703 (2007).
74. Mishra SK, Holzman S, Hoon MA. A nociceptive signaling role for neuromedin B. J. Neurosci., 32, 8686-8695 (2012).
75. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science, 325, 1531-1534 (2009).
76. Kagami S, Sugaya M, Suga H, Morimura S, Kai H, Ohmatsu H, Fujita H, Tsunemi Y, Sato S. Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis. J. Invest. Dermatol., 133, 1673-1675 (2013).
77. Tominaga M, Ogawa H, Takamori K. Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC/Nga mice: an atopic dermatitis model. J. Invest. Dermatol., 129, 2901-2905 (2009).
78. Andoh T, Kuwazono T, Lee JB, Kuraishi Y. Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. Peptides, 32, 2098-2103 (2011).
79. Koga K, Chen T, Li XY, Descalzi G, Ling J, Gu J, Zhuo M. Glutamate acts as a neurotransmitter for gastrin releasing peptidesensitive and insensitive itch-related synaptic transmission in mammalian spinal cord. Mol. Pain, 7, 47 (2011).
80. Su PY, Ko MC. The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats. J. Pharmacol. Exp. Ther., 337, 822-829 (2011).
81. Cridland RA, Henry JL. Bombesin, neuromedin C and neuromedin B given intrathecally facilitate the tail flick reflex in the rat. Brain Res., 584, 163-168 (1992).
82. Liu T, Berta T, Xu ZZ, Park CK, Zhang L, Lü N, Liu Q, Liu Y, Gao YJ, Liu YC, Ma Q, Dong X, Ji RR. TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice. J. Clin. Invest., 122, 2195-2207 (2012).
83. Liu T, Xu ZZ, Park CK, Berta T, Ji RR. Toll-like receptor 7 mediates pruritus. Nat. Neurosci., 13, 1460-1462 (2010).
84. Melzack R, Schecter B. Itch and vibration. Science, 147, 1047-1048 (1965).
85. Ward L, Wright E, McMahon SB. A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain. Pain, 64, 129-138 (1996).
86. Leibovici V, Magora F, Cohen S, Ingber A. Effects of virtual reality immersion and audiovisual distraction techniques for patients with pruritus. Pain Res. Manag., 14, 283-286 (2009).
87. Tohda C, Yamaguchi T, Kuraishi Y. Intracisternal injection of opioids induces itch-associated response through μ-opioid receptors in mice. Jpn. J. Pharmacol., 74, 77-82 (1997).
88. Yamaguchi T, Maekawa T, Nishikawa Y, Nojima H, Kaneko M, Kawakita T, Miyamoto T, Kuraishi Y. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J. Dermatol. Sci., 25, 20-28 (2001).
89. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat. Neurosci., 4, 72-77 (2001).
90. Jinks SL, Carstens E. Responses of superficial dorsal horn neurons to intradermal serotonin and other irritants: comparison with scratching behavior. J. Neurophysiol., 87, 1280-1289 (2002).
91. Omori Y, Andoh T, Shirakawa H, Ishida H, Hachiga T, Kuraishi Y. Itch-related responses of dorsal horn neurons to cutaneous allergic stimulation in mice. Neuroreport, 20, 478-481 (2009).
92. Davidson S, Zhang X, Khasabov SG, Simone DA, Giesler GJ Jr. Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat. Neurosci., 12, 544-546 (2009).
93. Akiyama T, Tominaga M, Carstens MI, Carstens EE. Site-dependent and state-dependent inhibition of pruritogen-responsive spinal neurons by scratching. Eur. J. Neurosci., 36, 2311-2316 (2012).
94. Akiyama T, Iodi Carstens M, Carstens E. Transmitters and pathways mediating inhibition of spinal itch-signaling neurons by scratching and other counterstimuli. PLoS ONE, 6, e22665 (2011).
95. Ross SE, Mardinly AR, McCord AE, Zurawski J, Cohen S, Jung C, Hu L, Mok SI, Shah A, Savner EM, Tolias C, Corfas R, Chen S, Inquimbert P, Xu Y, McInnes RR, Rice FL, Corfas G, Ma Q, Woolf CJ, Greenberg ME. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron, 65, 886-898 (2010).
96. Gotoh Y, Omori Y, Andoh T, Kuraishi Y. Tonic inhibition of allergic itch signaling by the descending noradrenergic system in mice. J. Pharmacol. Sci., 115, 417-420 (2011).
97. Gotoh Y, Andoh T, Kuraishi Y. Noradrenergic regulation of itch transmission in the spinal cord mediated by α-adrenoceptors. Neuropharmacology, 61, 825-831 (2011).
98. Gotoh Y, Andoh T, Kuraishi Y. Clonidine inhibits itch-related response through stimulation of α2-adrenoceptors in the spinal cord in mice. Eur. J. Pharmacol., 650, 215-219 (2011).
99. Reich A, Szepietowski JC. Opioid-induced pruritus: an update. Clin. Exp. Dermatol., 35, 2-6 (2010).
100. Phan NQ, Bernhard JD, Luger TA, Ständer S. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review. J. Am. Acad. Dermatol., 63, 680-688 (2010).
101. Phan NQ, Lotts T, Antal A, Bernhard JD, Ständer S. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm. Venereol., 92, 555-560 (2012).
102. Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, Loh HH, Chen ZF. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell, 147, 447-458 (2011).
103. Andoh T, Yageta Y, Konno M, Yamaguchi-Miyamoto T, Takahata H, Nojima H, Nemoto H, Kuraishi Y. Evidence for separate involvement of different μ-opioid receptor subtypes in itch and analgesia induced by supraspinal action of opioids. J. Pharmacol. Sci., 106, 667-670 (2008).